Pfizer expects $36 billion in sales from COVID-19 vaccine | The Hill: Healthcare Policy

admin November 02, 2021

Pfizer expects to earn about $36 billion in revenue this year from the COVID-19 vaccine developed with BioNTech, the company announced Tuesday, an increase from the previous estimate of $33.5 billion.During an earnings call, CEO Albert Bourla said...